The briefing
A study led by a University of Virginia researcher found that patients with major depressive disorder who did not respond adequately to standard antidepressants saw significant improvements in sexual function when lumateperone was added. The findings address a common quality-of-life issue in MDD treatment.
Original headline
Add-on drug lumateperone boosts sexual function in patients with depression